Curaleaf Holdings (CURLF) Other financing activities (2019 - 2024)

Curaleaf Holdings (CURLF) posted quarterly Other financing activities of $258000.0 for Q4 2024, down 93.67% year-on-year from $4.1 million in Q1 2024, and up 2445.45% on a QoQ basis from -$11000.0 in Q3 2024.

Curaleaf Holdings (CURLF) Other financing activities (2019 - 2024) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Other financing activities for 6 consecutive years, with $258000.0 the latest figure, recorded in Q4 2024.

  • Quarterly Other financing activities fell 93.67% year-over-year to $258000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $230000.0 (up 21.05% YoY) and the FY2025 annual result came in at $256000.0, up 64.1% from the prior year.
  • Other financing activities advanced to $258000.0 in Q4 2024 per CURLF's latest filing, from -$11000.0 in the prior quarter.
  • Over the last five years, Other financing activities for CURLF reached as high as $314.6 million in Q1 2021 and fell as low as -$311.9 million in Q2 2021.
  • A 5-year average of $398812.5 and a median of $308000.0 in 2020 frame the typical range for Other financing activities.
  • The largest YoY upside for Other financing activities was 43532.59% in 2021 against a maximum downside of 197520.25% in 2021.
  • Year by year, Other financing activities stood at $1.8 million in 2020, then plunged by 150.9% to -$904000.0 in 2021, then soared by 194.69% to $856000.0 in 2022, then surged by 376.52% to $4.1 million in 2023, then sank by 93.67% to $258000.0 in 2024.
  • According to Business Quant data, Other financing activities over the past three periods registered $258000.0, -$11000.0, and $4.1 million for Q4 2024, Q3 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn

Historic Data

Download Data
DateValue
Dec 31, 2024 258,000.00
Dec 31, 2024 258,000.00
Sep 30, 2024 -11,000.00
Sep 30, 2024 -11,000.00
Dec 31, 2023 4.08 Mn
Dec 31, 2023 4.08 Mn
Sep 30, 2023 -4.10 Mn
Sep 30, 2023 -4.10 Mn
Dec 31, 2022 856,000.00
Dec 31, 2022 856,000.00
Sep 30, 2022 -649,000.00
Sep 30, 2022 -649,000.00
Jun 30, 2022 -242.82 Mn
Jun 30, 2022 -242.82 Mn
Mar 31, 2022 242.60 Mn
Mar 31, 2022 242.60 Mn
Dec 31, 2021 -904,000.00
Dec 31, 2021 -904,000.00
Sep 30, 2021 1.39 Mn
Sep 30, 2021 1.39 Mn